Back to Search
Start Over
Upregulation of microRNA 344a-3p is involved in curcumin induced apoptosis in RT4 schwannoma cells.
- Source :
-
Cancer cell international [Cancer Cell Int] 2018 Dec 04; Vol. 18, pp. 199. Date of Electronic Publication: 2018 Dec 04 (Print Publication: 2018). - Publication Year :
- 2018
-
Abstract
- Background: Schwannoma arising from peripheral nervous sheaths is a benign tumor.<br />Methods: To evaluate cell cytotoxicity, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium reduction and terminal deoxynucleotidyltransferase UTP nick-end labeling (TUNEL) assays were used. A microRNA (miRNA) array was used to identify the miRNAs involved in curcumin-induced apoptosis. To examine miRNA expression, quantitative RT-PCR was used.<br />Results: In this study, curcumin exerted cellular cytotoxicity against RT4 schwannoma cells, with an increase in TUNEL-positive cells. Curcumin also activated the expression of apoptotic proteins, such as polyADP ribose polymerase, caspase-3, and caspase-9. The miRNA array revealed that seven miRNAs (miRNA 350, miRNA 17-2-3p, let 7e-3p, miRNA1224, miRNA 466b-1-3p, miRNA 18a-5p, and miRNA 322-5p) were downregulated following treatment with both 10 and 20 μM curcumin in RT4 cells, while four miRNAs (miRNA122-5p, miRNA 3473, miRNA182, and miRNA344a-3p) were upregulated. Interestingly, transfection with a miRNA 344a-3p mimic downregulated the mRNA expression of Bcl2 and upregulated that of Bax, Curcumin treatment in RT 4 cells also reduced the mRNA expression of Bcl2 and enhanced expression of Bax, Overexpression of miRNA344a-3p mimic combined with curcumin treatment activated the expression of apoptotic proteins, including procaspase-9 and cleaved caspase-3 while inhibition of miRNA 344a-3p using miR344a-3p inhibitor repressed cleaved caspase-3 and -9 in curcumin treated RT-4 cells compared to control.<br />Conclusions: Our findings demonstrate that curcumin induces apoptosis in schwannoma cells via miRNA 344a-3p. Thus, curcumin may serve as a potent therapeutic agent for the treatment of schwannoma.
Details
- Language :
- English
- ISSN :
- 1475-2867
- Volume :
- 18
- Database :
- MEDLINE
- Journal :
- Cancer cell international
- Publication Type :
- Academic Journal
- Accession number :
- 30534000
- Full Text :
- https://doi.org/10.1186/s12935-018-0693-x